Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 1:2018:7940603.
doi: 10.1155/2018/7940603. eCollection 2018.

The Effect of Anesthesia on the Immune System in Colorectal Cancer Patients

Affiliations
Review

The Effect of Anesthesia on the Immune System in Colorectal Cancer Patients

Yangjie Dang et al. Can J Gastroenterol Hepatol. .

Abstract

Colorectal cancer (CRC) is the key leading cause of high morbidity and mortality worldwide. Surgical excision is the most effective treatment for CRC. However, stress caused by surgery response can destroy the body's immunity and increase the likelihood of cancer dissemination and metastasis. Anesthesia is an effective way to control the stress response, and recent basic and clinical research has shown that anesthesia and related drugs can directly or indirectly affect the immune system of colorectal cancer patients during the perioperative period. Thus, these drugs may affect the prognosis of CRC surgery patients. This review is intended to summarize currently available data regarding the effects of anesthetics and related drugs on perioperative immune function and postoperative recurrence and metastasis in CRC patients. Determining the most suitable anesthesia for patients with CRC is of utmost importance.

PubMed Disclaimer

References

    1. Siegel R. L., Miller K. D., Jemal A. Cancer statistics. A Cancer Journal for Clinicians. 2017;67(1):7–30. doi: 10.3322/caac.21387. - DOI - PubMed
    1. Jinushi M. Yin and yang of tumor inflammation: how innate immune suppressors shape the tumor microenvironments. International Journal of Cancer. 2014;135(6):1277–1285. doi: 10.1002/ijc.28626. - DOI - PubMed
    1. Dunn G. P., Old L. J., Schreiber R. D. The three Es of cancer immunoediting. Annual Review of Immunology. 2004;22:329–360. doi: 10.1146/annurev.immunol.22.012703.104803. - DOI - PubMed
    1. Shankaran V., et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410, article 1107 - PubMed
    1. Biswas S. K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature Immunology. 2010;11, article 889 - PubMed

LinkOut - more resources